Identifying Potential Therapeutics for PABPC1P4-related Diseases

Target Name: PABPC1P4

NCBI ID: G341315

PABPC1P4

Other Name(s): PABPCP5 | PABPL2 | Poly(A) binding protein, cytoplasmic 1 pseudogene 4 | poly(A) binding protein cytoplasmic 1 pseudogene 4

Identifying Potential Therapeutics for PABPC1P4-related Diseases

PABPC1P4 (PABPCP5) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to be involved in the regulation of blood pressure. Several studies have suggested that PABPC1P4 may be a drug target or biomarker for various cardiovascular diseases, including hypertension, heart failure, and diabetes.

One of the key functions of PABPC1P4 is its role in the regulation of blood pressure. This is important because high blood pressure is a major risk factor for a wide range of cardiovascular diseases, including heart disease, stroke, and diabetes. The normal function of the blood vessels is to maintain a constant pressure on the blood, but when the pressure drops or increases, the blood vessels respond accordingly. PABPC1P4 is involved in this process by helping the blood vessels to relax and widen when pressure is low and to constrict and narrow when pressure is high.

Another function of PABPC1P4 is its role in the regulation of inflammation. inflammation is a natural response of the immune system, but when inflammation becomes excessive or lasts for an extended period of time, it can contribute to the development of various cardiovascular diseases. PABPC1P4 has been shown to play a role in the regulation of inflammation by helping to control the movement of immune cells into the bloodstream.

In addition, PABPC1P4 is also known to be involved in the regulation of cellular processes that are important for maintaining the structure and function of cells. This includes the regulation of cell division, the production of new cells, and the maintenance of cellular networks.

PABPC1P4 is also a protein that has been shown to play a role in the development and progression of various diseases, including cancer. Studies have shown that PABPC1P4 is often expressed in the cells of people with cancer, and that it may be a useful biomarker for the disease.

Overall, PABPC1P4 is a protein that is involved in a wide range of important cellular processes that are essential for maintaining the health and function of cells. While more research is needed to fully understand its role in the regulation of blood pressure and other cardiovascular diseases, it is clear that PABPC1P4 is a promising target for future research and treatment.

Protein Name: Poly(A) Binding Protein Cytoplasmic 1 Pseudogene 4

The "PABPC1P4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PABPC1P4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets